Article info

Download PDFPDF
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Authors

  1. Correspondence to Dr Oliver Distler, Department of Rheumatology, University Hospital Zurich, Zurich 8091, Switzerland; oliver.distler{at}usz.ch
View Full Text

Citation

Mihai C, Dobrota R, Schröder M, et al
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Publication history

  • Received March 27, 2020
  • Accepted March 30, 2020
  • First published April 2, 2020.
Online issue publication 
April 12, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.